Gamida Cell has named Rory Nealon as Chief Financial Officer. Rory Nealon was the co-founder, Chief Financial and Operating Officer at Amryt Pharma from 2015 through its acquisition in 2023. Before joining Amryt, he served executive roles at Trinity Biotech, first as the Chief Financial Officer then as the Chief Operations Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.017 USD | +2.41% | -.--% | -95.88% |
06-18 | Gamida Cell Names Rory Nealon as Chief Financial Officer | CI |
06-18 | Gamida Cell Names Sheila Frame as Chief Commercial Officer | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2.06 USD | -0.96% | -20.46% | 19.5M | ||
0.017 USD | +2.41% | -.--% | 2.62M | ||
1st Jan change | Capi. | |
---|---|---|
-95.88% | 2.62M | |
+16.49% | 122B | |
+21.73% | 115B | |
+21.80% | 26.64B | |
-21.81% | 19.91B | |
-16.87% | 16.32B | |
-44.74% | 15.52B | |
-18.81% | 15.49B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- GMDA Stock
- News Gamida Cell Ltd.
- Gamida Cell Names Rory Nealon as Chief Financial Officer